Tahoe

Drug Discovery · South San Francisco, CA · Founded 2022 · Privately Held (backing)

Operator of a biotech company intended to combine data to find better targets and drugs that can treat patients. Tahoe is based in South San Francisco, CA and was founded in 2022. It was valued at $131 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $50 million across 1 recorded round; the latest was a $35 million Series A in Aug 2025.

PMV mark · valuation
$131.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$50.0M
Last round
Early Stage VC (Series A)
Aug 2025
Cap table — not yet on record

Tahoe's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Tahoe with a free account
  • ·The complete investor list: 12 names
  • ·Watch Tahoe: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Tahoe

Where does Tahoe's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Tahoe's 1 recorded funding rounds.